Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Rogers Corp. (NY: ROG)
46.22 USD  +0.17 (+0.37%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Rogers Corp.
 
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
PREVIEW-New cancer data may be tonic for sickly Roche
October 05, 2010
* Roche drugs in focus at Oct 8-12 European cancer congress Read More
category companyNews
from Reuters: Company News
UPDATE 2-Novartis takes further step to streamline portfolio
October 05, 2010
* Novartis shares up 0.6 percent, in line with sector index Read More
category companyNews
from Reuters: Company News
The Week in Review: Deals and Products
October 02, 2010
CCB’s $400 million China health care fund may invest in ex-China biopharmas; Tongjitang Chinese Medicines will sell off three divisions as it prepares to go private; Roche is making its cancer... Read More
from ChinaBio® Today
The Week in Review: Deals and Products
October 02, 2010
CCB’s $400 million China health care fund may invest in ex-China biopharmas; Tongjitang Chinese Medicines will sell off three divisions as it prepares to go private; Roche is making its cancer... Read More
from ChinaBio® Today
Roche Officially Launches Avastin after Fake Version Caused Problems
September 29, 2010
Shanghai Roche Pharma, the first China JV set up by Roche, officially announced on its website that its cancer treatment Avastin has been approved for sale in China. The announcement comes after... Read More
from ChinaBio® Today
UPDATE 1-Siemens sees Q4 operating profit up yr/yr
September 27, 2010
* Siemens says sees Q4 oper profit up vs 1.9 bln eur last yr * Says figure excludes impairment of up to 1.4 bln eur Read More
category companyNews
from Reuters: Company News
UPDATE 1-EU agency reviews Roche's Avastin in breast cancer
September 24, 2010
ZURICH, Sept 24 (Reuters) - European healthcare regulators are reviewing the benefits of using Roche's top-selling Avastin drug in breast cancer, in the light of fresh clinical trial results. Read More
category companyNews
from Reuters: Company News
Rogers Communications (ROG) Prices $900M Senior Notes Offering
September 22, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5991503 for the full story. Read More
from StreetInsider.com News Articles
Europe Factors-Shares set to bounce back after Fed
September 22, 2010
(Adds company news, detail, quotes; updates snapshot table) Read More
category companyNews
from Reuters: Company News
UPDATE 1-Glaxo says Roche's Herceptin infringes patents
September 21, 2010
* Genentech says aware of lawsuit (Adds Genentech comment in paragraph five) Read More
category companyNews
from Reuters: Company News
Glaxo says Roche's Herceptin infringes patents
September 21, 2010
WILMINGTON, Del., Sept 21 (Reuters) - Drugmaker GlaxoSmithKline sued Swiss rival Roche Holding AG on Tuesday for infringing a patent when it produces its cancer drug herceptin, according to court... Read More
category companyNews
from Reuters: Company News
DEALTALK-UPDATE 1-Savient's gout drug nod may trigger bid war
September 21, 2010
* Aletrnative TNF-alpha inhibitors coming up to patent expiry (For more Reuters DEALTALKs; [DEALTALK/]) Read More
category companyNews
from Reuters: Company News
DEALTALK-Savient's gout drug nod may trigger bid war
September 21, 2010
* Aletrnative TNF-alpha inhibitors coming up to patent expiry (For more Reuters DEALTALKs; [DEALTALK/]) Read More
category companyNews
from Reuters: Company News
Obesity, blindness researchers win US Lasker awards
September 21, 2010
WASHINGTON, Sept 21 (Reuters) - Researchers who discovered a hormone intimately linked to obesity, who found a protein linked to a common form of blindness and who worked on genetic blood diseases won... Read More
category companyNews
from Reuters: Company News
UPDATE 1-Roche's Avastin fails in post-surgery colon study
September 20, 2010
* Study shows Avastin doesn't improve disease-free survival Read More
category companyNews
from Reuters: Company News
UPDATE 1-U.S. delays breast cancer ruling for Roche's Avastin
September 17, 2010
WASHINGTON, Sept 17 (Reuters) - U.S. regulators have extended by three months a review of Roche Holding AG's blockbuster drug Avastin in breast cancer, the company said on Friday. Read More
category companyNews
from Reuters: Company News
Acne depression link may not be due to drugs-study
September 16, 2010
* Study finds strong link between depression and severe acne Read More
category companyNews
from Reuters: Company News
FACTBOX-Timeline and facts about obesity drugs
September 15, 2010
WASHINGTON, Sept 15 (Reuters) - An advisory panel that met Wednesday was evenly divided on whether a weight-loss drug from Abbott Laboratories was too dangerous to stay on the market. [ID:nN15144589] Read More
category companyNews
from Reuters: Company News
RPT-SPECIAL REPORT-Has Roche got the right medicine?
September 15, 2010
Avastin was supposed to help Roche regain the top slot in the global drugs market, with analysts tipping it to be the world's biggest selling drug by 2014. But sales expectations have plunged by $1.1... Read More
category companyNews
from Reuters: Company News
Drugmakers lead European shares lower at midday
September 15, 2010
* AstraZeneca slips on Brilinta delay; other pharmas fall Read More
category companyNews
from Reuters: Company News
UPDATE 2-FDA mulls label changes for some osteoporosis drugs
September 14, 2010
* FDA advises doctors: be aware of unusual femur fractures Read More
category companyNews
from Reuters: Company News
PRESS DIGEST - New York Times business news - Sept 13
September 13, 2010
Sept 13 (Reuters) - The following were the top stories in The New York Times business pages on Monday. Reuters has not verified these stories and does not vouch for their accuracy. Read More
category companyNews
from Reuters: Company News
The Week in Review: Shanghai Pharma Plans $1.2 Billion IPO
September 11, 2010
Shanghai Pharmaceuticals will raise 8 billion RMB ($1.2 billion) in a Hong Kong IPO; Roche plans to increase both its China investments and headcount; EntreMed raised $5.1 million in a private... Read More
from ChinaBio® Today
UPDATE 1-Roche suspends dosing in diabetes drug trials
September 10, 2010
NEW YORK, Sept 10 (Reuters) - Roche Holding has stopped giving patients its experimental diabetes treatment taspoglutide in late stage clinical trials due to a high rate of adverse reactions, marking a... Read More
category companyNews
from Reuters: Company News
FACTBOX-Timeline and facts about obesity drugs
September 09, 2010
WASHINGTON, Sept 9 (Reuters) - Three new weight-loss drugs are up for Food and Drug Administration review this year. One is Arena Pharmaceuticals Inc's candidate Lorqess or lorcaserin, the focus of a... Read More
category companyNews
from Reuters: Company News
Roche to Ramp Up China Investment, Headcount
September 09, 2010
Roche Holding AG will increase both its China investments and headcount, said Severin Schwan, CEO of the company, in an interview with The Wall Street Journal . Schwan was not specific about the dollar... Read More
from ChinaBio® Today
PRESS DIGEST - New York Times business news - Sept 9
September 09, 2010
Sept 9 (Reuters) - The following were the top stories in The New York Times business pages on Thursday. Reuters has not verified these stories and does not vouch for their accuracy. Read More
category companyNews
from Reuters: Company News
CORRECTED-Developers of cancer pill tout biopsy/tweak method
September 08, 2010
(Corrects spelling of company throughout to Plexxikon from Plexxicon) Read More
category companyNews
from Reuters: Company News
Top Genentech research exec departing for academia
September 08, 2010
NEW YORK, Sept 8 (Reuters) - The No. 2 research executive at Genentech is leaving for a post in academia -- marking one of the highest-profile departures since the U.S. biotechnology company was... Read More
category companyNews
from Reuters: Company News
UPDATE 2-Shanghai Pharma to raise $1.2 bln in HK to fund M&A
September 08, 2010
* Shares suspended since Tuesday pending announcement (Adds more details, background) Read More
category companyNews
from Reuters: Company News
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here